IP Library Patent Application 15335926
Patent Application
App. No. 15/335,926

NOVEL LACTAMS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/335,926
Abstract

The present invention relates to novel lactams of formulae (I) and (II). The present invention further relates to the use of these compounds in the treatment of microbial infections and microbial contamination of surfaces, particularly infections and surface contaminations characterised by biofilm formation. Further provided are compounds of formula (I) and (II) substituted with acrylate or methacrylate groups and their attachment to surfaces or polymers to inhibit microbial contamination.

Claims (24)

1 - 20 . (canceled)

21 . A compound of formula I:

wherein:

R 1 is hydrogen;

R 2 is selected from the group consisting of heterocyclyl, heteroaryl, aryl and arylalkyl;

R 3 is selected from the group consisting of hydrogen, hydroxy, alkyl, cycloalkyl, alkoxy, oxoalkyl, alkenyl, heterocyclyl, heteroaryl, cycloalkyl, aryl, arylalkyl, and —C(O)CR 6 ═CH 2 ;

R 4 and R 5 are each hydrogen;

R 6 is selected from the group consisting of hydrogen or methyl.

22 . The compound of claim 21 , wherein R 3 is selected from hydrogen, methyl and phenyl.

23 . The compound of claim 21 , wherein R 2 is phenyl.

24 . The compound of claim 21 , wherein R 2 is mono-substituted phenyl.

25 . A compound of formula II:

wherein

R 1 is hydrogen;

R 2 is mono-substituted phenyl;

R 3 is selected from the group consisting of hydrogen, hydroxy, alkyl, cycloalkyl, alkoxy, oxoalkyl, alkenyl, heterocyclyl, heteroaryl, cycloalkyl, aryl, arylalkyl, and —C(O)CR 6 ═CH 2 ;

R 4 and R 5 are each hydrogen;

R 6 is selected from the group consisting of hydrogen or methyl.

R 7 is hydrogen.

26 . The compound of claim 25 , wherein R 3 is selected from hydrogen, methyl and phenyl.

27 . A method of treating a microbial infection in a subject, the method comprising administering a compound according to claim 21 to the subject.

28 . A method according to claim 27 wherein the infection is a bacterial infection.

29 . A method according to claim 27 wherein the infection is characterised by biofilm formation.

30 . A method of inhibiting microbial contamination of a surface, the method comprising administering a compound according to claim 21 to the surface.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2019
From: KUMAR, NARESH; ISKANDER, GEORGE
To: BIOSIGNAL LIMITED
Reel/Frame 048625/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2019
From: RGM MEDIA LIMITED
To: UNILEVER PLC
Reel/Frame 048627/0982 →
CHANGE OF NAME Recorded Mar 18, 2019
From: BIOSIGNAL LIMITED
To: RGM MEDIA LIMITED
Reel/Frame 048628/0023 →